2011
Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study
Swede H, Gregorio DI, Tannenbaum SH, Brockmeyer JA, Ambrosone C, Wilson LL, Pensa MA, Gonsalves L, Stevens RG, Runowicz CD. Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study. Clinical Breast Cancer 2011, 11: 332-341. PMID: 21729670, PMCID: PMC4459583, DOI: 10.1016/j.clbc.2011.04.004.Peer-Reviewed Original ResearchConceptsConnecticut Tumor RegistryTN breast cancerBlack patientsBreast cancerSurvival disparitiesWhite patientsLocal diseaseHER2 statusTN statusNational Cancer Institute's Surveillance EpidemiologyPrimary invasive breast cancerTriple-negative breast cancerAdvanced breast cancerInvasive breast cancerTriple-negative subtypeRisk of deathStatewide cancer registryAdvanced diseaseDuctal tumorsLobular cancerPrognostic roleTumor RegistryCancer RegistryHistologic subtypeRegional disease
2009
Patterns of HER2 testing in the management of primary breast cancer
Pensa M, Swede H, Brockmeyer JA, Gregorio DI. Patterns of HER2 testing in the management of primary breast cancer. Cancer Epidemiology 2009, 33: 113-117. PMID: 19679057, DOI: 10.1016/j.canep.2009.06.010.Peer-Reviewed Original ResearchConceptsLymph node statusHER2 testingNode statusTumor gradeBreast cancerHuman epidermal growth factor receptor 2 (HER2) statusEpidermal growth factor receptor 2 statusPrimary invasive breast carcinomasWhite womenReceipt of testingConnecticut Tumor RegistryYear of diagnosisInvasive breast cancerPopulation-based patternsPrimary breast cancerTime of diagnosisBreast cancer patientsEstrogen receptor statusTumors of patientsInvasive breast carcinomaAfrican American womenWomen’s prognosisClinicopathologic factorsER statusReceptor status